Savita Kanade, MSc

Pune, India

Role:

Staff

Community Coordinator

Savita Kanade is working as Community and Outreach Coordinator for NIH funded clinical trials at BJGMC-CRS, Pune, India. At present she is serving as Field Representative on A5300B/I2003B/PHOENIx study.

As part of NIH funded HIV/AIDS and Tuberculosis clinical trials, since 2007, she was involved in recruitment and retention of participants in clinical trials and in identifying issues related to understanding barriers to participation and retention, addressing stigma and discrimination, administering informed consent, managing socio-cultural issues during the study participation, addressing opportunistic infections such as TB, etc.

She is also involved in networking and communication with state level agencies like National TB Elimination Programme (NTEP), Maharashtra State AIDS Control Society (MSACS) and various NGOs working for HIV/AIDS and Tuberculosis.

She is acting as site liaison to the Community Advisory Board (CAB) and facilitates local CAB representation at GCAB and CSS at ACTG network and ICAB at IMPAACT network.

She is been involved in translating the study related material (informed consent forms, education material, CRFs, study flyers, etc.) into local language.

As an Anthropologist, she was involved in public health research for 15 years. She was active in research related to reproductive health, family planning, gender based domestic violence, formation of sexual partnerships, pathways in resolving unintended pregnancy among youth, and parent child communication on sex related issues.

Studies/Projects
Publications
News

Increasing Market and Public Health Outcomes Through Scaling Up Affordable Access Models of Short Course Preventive Therapy for TB (IMPAACT4TB)

Post Date:

2019-12-17

Countries:

India

Clinical Sites:

BJGMC

NIRT

Primary Objective: This study is being conducted in Brazil, Cambodia, China, Ethiopia, Ghana, Haiti, India, Indonesia, Kenya, Malawi, Mozambique, South Africa, Tanzania, and Zimbabwe. The overall goal is to reduce TB incidence among (1) people living with HIV who are on antiretroviral therapy, and...

A5300B/I2003B: Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients (PHOENIx)

Post Date:

2019-08-19

Countries:

India

Clinical Sites:

BJGMC

Dr. Amita Gupta is Protocol Co-chair for this multinational clinical trial. BACKGROUND The World Health Organization (WHO) estimates that there were 480,000 incident cases of MDR-TB globally in 2015. MDR-TB has been shown to be almost twice as common in TB...

A5300B/I2003B: Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients (PHOENIx)

Post Date:

2019-08-19

Countries:

India

Clinical Sites:

BJGMC

A5300/IMPAACT2003: Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design

Post Date:

2015-09-01

Countries:

India

Clinical Sites:

BJGMC

This clinical trial was terminated July 18, 2017. It was a study conducted under both the AIDS Clinical Trial Group (ACTG) and the the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network, and funded by the U.S. National Institutes of Health. Dr...

Diagnosis of Tuberculosis Infection and Th1 Immune Response in Pregnant Women in India

Post Date:

2014-09-01

Countries:

India

Clinical Sites:

BJGMC

NIRT

This study was terminated April 16, 2018. Tuberculosis (TB) disease is a major cause of mortality among Indian women of reproductive age; approximately 20-50% of women in India are latently infected with Mycobacterium tuberculosis (MTB). Due to immune...

Community Home Based India Prevention of Mother to Child Transmission of HIV (COMBIND)

Post Date:

2013-09-02

Countries:

India

Clinical Sites:

BJGMC

This study ended May 14, 2019. CCGHE is assessing whether equipping Community Health Workers with mobile health technology and involving them in technology training and personal empowerment seminars can help prevent mother-to-child...

BWI CTU: Baltimore-Washington-India Clinical Trials Unit

Post Date:

2007-02-02

Countries:

India

United States

Clinical Sites:

BJGMC

Comprising clinical trial sites at Johns Hopkins Medicine in Baltimore, Whitman Walker Health in Washington, DC, and the BJGMC-CCGHE collaboration in Pune, India, the Baltimore-Washington-India Clinical Trials Unit (BWI-CTU) is one of only 25 international HIV/TB clinical trial sites funded by the...

A mobile health-facilitated behavioral intervention for community health workers improves exclusive breastfeeding and early infant HIV diagnosis in India: A cluster randomized trial

Post Date:

2020-07-03

Countries:

India

Clinical Sites:

BJGMC

Publication:

Journal of the International AIDS Society

When community health workers used a mobile health intervention with HIV+ women to deliver care, there was a higher uptake of exclusive breastfeeding at two months and early infant HIV diagnosis at six weeks

Acceptability and Feasibility of a Behavioral and Mobile Health Intervention (COMBIND) Shown to Increase Uptake of Prevention of Mother to Child Transmission (PMTCT) Care in India

Post Date:

2020-05-24

Countries:

India

Publication:

BMC Public Health

A cluster-randomized trial recently demonstrated that an integrated behavioral and mobile technology intervention improved uptake of key components of a Prevention of Mother to Child Transmission (PMTCT) Option B+ program, among HIV- infected pregnant/breastfeeding women in India.

Drug-resistant Enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in Pune, India

Post Date:

2018-10-04

Countries:

India

Clinical Sites:

BJGMC

Publication:

BMC Infectious Diseases

BACKGROUND: Healthcare exposure may increase drug-resistant Enterobacteriaceae colonization risk. Nascent antimicrobial stewardship efforts in low- and middle-income countries require setting-specific data. We aimed to evaluate risk factors for inpatient drug resistant...

Challenges and opportunities for outreach workers in the Prevention of Mother to Child Transmission of HIV (PMTCT) program in India

Post Date:

2018-09-04

Countries:

India

Publication:

PLoS One

PLoS One: Prevention of Mother-to-Child Transmission of HIV program in India is one of the largest in the world, and it relies on outreach workers. Our study looked at challenges and opportunities for outreach workers.

Antibiotic utilization and the role of suspected and diagnosed mosquito borne illness among adults and children with acute febrile illness in Pune, India

Post Date:

2018-05-02

Countries:

India

Clinical Sites:

BJGMC

Publication:

Clinical Infectious Diseases

Post Date:

2020-12-07

Reporting from the virtual 51st Union Conference on Lung Health, the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) announced promising findings from 2 TB trials

BJGMC Team Convenes PHOENIx Pre-study Event for Maharashtra Government TB Program Officials

Post Date:

2019-08-19

Collaboration and coordination with local government TB program officials are critical for ensuring transparency and a shared understanding of the study’s purpose, methods, consent process, logistics, and potential implications for India’s national TB control efforts.

BJGMC Clinical Research Team Exceeds 6,000 Participant Enrollments in 4 Years

Post Date:

Post Date:

2016-01-28

Source:

Infectious Disease Advisor

Pregnancy may confound tuberculosis (TB) tests results in women with HIV, according to research published in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine .

BJGMC Clinical Research Site Observes World AIDS Day

Post Date:

2015-12-14

Pune, India—To mark the struggle of those living with HIV and in commemoration of those who have lost their lives, the Clinical Research Site at Byramjee Jeejeebhoy Government Medical College (BJGMC CRS) participated in the National AIDS Trust’s World AIDS Day ...